24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
OrbiMed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:46
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
15:04
Laser beams and battlefield proof: Israeli arms firms sell their war story in Paris
14:29
CTech's War Room: Live Log - June 15, 2025
14:28
Cyberattacks against Israel surge 700% in two days, says Radware
More stories
Buzz
Most popular
Daily
Weekly
1
Google’s $32 billion acquisition of Wiz draws antitrust attention
2
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
3
Navan to file confidentially for IPO, betting on market reopening
4
Andreessen Horowitz targets elite IDF alumni for startup accelerator
5
Intel to cut jobs at Kiryat Gat fab, says it must “position our business for the future”
More news
OrbiMed
4 stories about OrbiMed
OrbiMed chooses against raising a third Israeli healthcare-dedicated fund
07.01.21
|
Meir Orbach
The investment firm raised a $307 million fund in 2016, but will not be founding another in a blow to the local ecosystem
Biological cancer treatment company Novellus raises $57 million
22.09.20
|
Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb
04.12.17
|
Meir Orbach
ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases